Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-03

Clinical Trial Update: Drug Interaction Study of Apixaban With Cyclosporine or Tacrolimus in Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial updating the interaction of apixaban with cyclosporine or tacrolimus in transplant recipients, focusing on pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apixaban (apixaban)

Snippet

Sponsor: University of Saskatchewan | Conditions: Pharmacokinetics, Kidney Transplant | Phase 4 | Status: COMPLETED